As the global economy mends, the 2021 growth of RNA Medicine will have significant change from previous year. According to our (LP Information) latest study, the global RNA Medicine market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global RNA Medicine market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028. The United States RNA Medicine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global RNA Medicine market, reaching US$ million by the year 2028. As for the Europe RNA Medicine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period. Global main RNA Medicine players cover Pfizer, Roche, Sanofi-Aventis, and Abbott Laboratories, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021. This report presents a comprehensive overview, market shares, and growth opportunities of RNA Medicine market by product type, application, key players and key regions and countries. Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7. siRNA ASO miRNA Nucleic Acid Aptamers Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8. Cancer Diabetes Tuberculosis Cardiovascular Diseases Others This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8. Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3. Pfizer Roche Sanofi-Aventis Abbott Laboratories Arrowhead Pharmaceuticals Benitec Biopharma Calimmune Inc Dicerna Gradalis Quark RXi Senesco Silence Therapeutics Silenseed Tekmira Alnylam Pharmaceuticals
1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 2 Executive Summary 2.1 World Market Overview 2.1.1 Global RNA Medicine Market Size 2017-2028 2.1.2 RNA Medicine Market Size CAGR by Region 2017 VS
